A potentially pivotal single arm Phase 2 study in post-CAR T LBCL patients

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 12 Nov 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

08 Nov 2023 Status changed from planning to recruiting, in November.
26 Jun 2023 According to an Adicet Bio media release, the company plans to initiate this trial in the first half of 2024.
15 Mar 2023 According to an Adicet Bio media release, the company plan to discuss the design with the FDA in the second quarter of this year and initiate the pivotal portion of the study in the second half of the year, potentially in the third quarter.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com